Access all of the content
The COVID-19 pandemic has had a huge impact on us all, but particularly patients with cancer. Prof. Mark Lawler tells touchONCOLOGY about the data he presented at this year’s European Cancer Summit, the challenges patients with cancer face as a result of the pandemic, and steps taken to help mitigate this effect.
- You presented data at this year’s European Cancer Summit on the impact of COVID-19 on cancer services and cancer patients – what was the spark for this work and what did you find?
- What challenges does this work reveal for European patients with cancer?
- What is the likely impact of the pandemic on cancer deaths in Europe?
- How has the clinical and research community responded to the pandemic?
- What has the European Cancer Organisation done to try to mitigate the impact of the pandemic?
Speaker Disclosures: Prof. Mark Lawler has an unrestricted educational grant from Pfizer for research unrelated to the work described in this interview. Prof. Lawler also has received honoraria from Pfizer, EMD Serono, Roche and Bristol Myers Squibb for presentations of the work described in this interview.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the European Cancer Summit 2020.
Share this Video
Related Videos In COVID-19
Mark Lawler, European Cancer Summit 2021: Time To Act: COVID-19 & Cancer Campaign
We were delighted to catch up with Prof Mark Lawler to discuss the challenges that the COVID-19 pandemic has had on cancer care in Europe, and the key objectives and messages of the Time To Act: COVID-19 & Cancer campaign. Questions 1. What has been the impact of the COVID-19 pandemic on cancer screening and […]
Scott Shepherd, ESMO 2021: The CAPTURE Study: Adaptive Immunity to SARS-CoV-2 Infection and Vaccination in Cancer Patients (Part Two)
touchONCOLOGY joins Dr Scott Shepherd (London, UK), to discuss his presentation at ESMO 2021 on the CAPTURE study exploring adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients. To view Part One click here. Questions 1. How did immune responses relate to cancer stage and disease status? (00:18-03:26) 2. What are the implications of […]
Scott Shepherd, ESMO 2021: The CAPTURE Study: Adaptive Immunity to SARS-CoV-2 Infection and Vaccination in Cancer Patients (Part One)
touchONCOLOGY joins Dr Scott Shepherd (London, UK), to discuss his presentation at ESMO 2021 on the CAPTURE study exploring adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients. To view Part Two click here. Questions 1. What were the aims and design of the CAPTURE study? (00:18-02:25) 2. What were the study findings in […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!